DNA Stock Price, Chart, Stats & News

Ginkgo Bioworks Holdings, Inc.
Save
635.61M
Market cap
–
Current P/E
–
Forward P/E
DNA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 81.48% |
Operating margin | -185.29% |
Pretax margin | -184.30% |
Net margin | -183.81% |
Effective tax rate | 0.27% |
ROA | -27.93% |
ROE | -53.72% |
D/E | 0.82x |
Interest coverage ratio | – |
DNA valuation
P/E | – |
P/S | 2.16x |
P/B | 0.65x |
P/CF | -1.92x |
P/FCF | -1.89x |
P/OCF | -1.92x |
PEG | -0.10x |
EV multiple | -0.54x |
About
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum.
Similar securities
Based on sector and market capitalization
Report issue











